SMS Lifesciences India Ltd - 540679 - Reappointment Of Managing Director
Mr. TVVSN Murthy has been reappointed as Managing Director for a further period of 3 (three) years w.e.f. June 1, 2022, subject to the approval of Shareholders.29-05-2022
29-05-2022
SMS Lifesciences India Ltd - 540679 - Financial Results For Quarter And Year Ended March 31, 2022
Copy of Audited Results.29-05-2022
SMS Lifesciences India Ltd - 540679 - Board recommends Dividend
SMS Lifesciences India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2022, inter alia, has recommended a dividend of Rs. 1.50/- (15%) per equity share Rs. 10/- face value, for the year 2021-22, subject to the approval of the Shareholders at the ensuing 16th Annual General Meeting (AGM) of the Company.28-05-2022
SMS Lifesciences India Ltd - 540679 - Board Meeting Outcome for Financial Results For Quarter And Year Ended March 31, 2022
Enclosed is the Outcome of the Board Meeting.28-05-2022
SMS Lifesciences India Ltd - 540679 - Board to consider Dividend
SMS Lifesciences India Ltd has informed BSE that a meeting of the Board of Directors of the Company has been scheduled to be held on May 28, 2022, inter alio, to consider the following:1. Audited financial results (Standalone and Consolidated) of the Company for the fourth quarter and year ended March 31. 2022,2. Discuss to recommend dividends for the financial year 2021-22, if any,The trading window for dealing in the securities of the Company shall remain closed for all the Designated Persons and their Immediate Relatives pursuant to Clouse 4 of Schedule B of the SEBI (Prohibition of Insider Trading) Regulations. 2015 (Insider Trading Regulations) the trading window shall remain closed till May 31, 2022.21-05-2022
SMS Lifesciences India Ltd - 540679 - Board Meeting Intimation for Approval Of The Audited Financial Results For The Quarter & Year Ended March 31, 2022
SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2022 ,inter alia, to consider and approve i) audited financial results (Standalone and Consolidated) of the Company for the fourth quarter and year ended March 31, 2022, ii) discuss to recommend dividends for the financial year 2021-22, if any, iii) any other item as may be decided by the Board of Directors.21-05-2022
SMS Lifesciences India Ltd - 540679 - Announcement under Regulation 30 (LODR)-Diversification / Disinvestment
Update on disinvestment in Mahi Drugs Private Limited.07-05-2022
SMS Lifesciences India Ltd - 540679 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Update on issue of duplicate share certificate pursuant to our Intimation dated April 14, 2022.07-05-2022
SMS Lifesciences India Ltd - 540679 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Suresh Babu Potluri20-04-2022